MUNICH—Rodenstock Group, a global innovation leader in vision care and manufacturer of biometric lenses, has announced its results for the financial year 2023. Driven by continued strong sales growth of its B.I.G. Vision product portfolio of biometric progressive lenses and the launch of MyCon lenses for children, the group increased consolidated pro-forma net sales to €506.1 million, a slight revenue increase of 0.2 percent. Previous year net sales were €505.3 million on a like-for-like basis. Rodenstock also reported 8 percent sales growth of the B.I.G. Vision product portfolio of biometric progressive lenses during 2023.

During 2023, the sale of the Rodenstock Group's eyewear business, as reported in VMAIL, marked the completion of the company’s transformation into a pure-play Med-Tech company, Rodenstock said.

Marcus Desimoni, CEO of the Rodenstock Group, said, “2023 was another good year for Rodenstock and brought about significant milestones. With the strong performance of our B.I.G. Vision product portfolio, and strategic launches such as MyCon lenses, we laid the groundwork for further innovation and global expansion in the future—always with a focus on customer benefits. This can be largely attributed to the commitment and dedication of our entire team.”

Rodenstock Group generated recurring EBITDA of €122.3 million in 2023, up 0.3 percent compared with the previous year on a pro-forma basis. 

The company said, the group’s performance was driven by its pursuit of Rodenstock’s B.I.G. Vision strategy, which built the framework for the company’s transformation into a leading Med-Tech company leading the paradigm shift in individual lenses. The strong debut of MyCon lenses in the European market marked a further successful product innovation by Rodenstock. The novel lenses for children are designed to correct short-sightedness, ensure sharp vision, and counteract the progression of myopia, the company said.

“Our 2023 performance underscores our continued path as a pure Med-Tech company with a global footprint,” said Dr. Mani Herold, CFO of the Rodenstock Group. “We implement our strategic decisions rigorously to drive operational efficiency for long term, sustainable growth and strong financial performance.”